News
Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...
LOS ALAMITOS, Calif., May 7, 2025 /PRNewswire/ -- Epson Robots, the #1 SCARA robot manufacturer in the world, is redefining the role of automation by bringing manufacturing beyond the factory ...
4don MSN
Fast forward to 2025, and a whole new market has emerged — gummies to enhance your hair health, powders to boost collagen, ...
TCI Biotech, a global leader in health and wellness innovation, will mark a major milestone at Vitafoods Europe 2025 with a dynamic showcase of its rebranded identity, next-gen CDMO+ model, and ...
Regeneron develops new medicines and it rang up $3.7 billion in sales for its anti-inflammatory drug Dupixent as a treatment for eczema, asthma and chronic obstructive pulmonary disease, in its latest ...
(MENAFN- PR Newswire) By integrating Epson advanced automation solutions – including the T3 All-in-One SCARA Robot, Epson RC+ ® software, Color Control Technology, and Spectroscopic Vision ...
MIT today launched its Initiative for New Manufacturing (INM), an Institute-wide effort to reinfuse U.S. industrial ...
Despite recent corrections, the Piramal Pharma stock has shown remarkable resilience, tripling investor wealth since 2023-24.
In its latest earnings report, Walmart said that it would begin to increase prices on products because of tariffs ... Friday its preliminary index of consumer sentiment for May was 50.8, down ...
9d
Pharmaceutical Technology on MSNCan pharma tariffs “Make America Manufacture Again”?Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.
The global Healthcare Contract Manufacturing Market size is projected to be valued at USD 183.7 billion in 2023 and reach USD 347.5 billion by 2030, growing ...
The result is likely to be not a fully technopolar world but a more technopolar United States mirrored by a tightly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results